Correlation Between Biomerica and NanoVibronix
Can any of the company-specific risk be diversified away by investing in both Biomerica and NanoVibronix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomerica and NanoVibronix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomerica and NanoVibronix, you can compare the effects of market volatilities on Biomerica and NanoVibronix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomerica with a short position of NanoVibronix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomerica and NanoVibronix.
Diversification Opportunities for Biomerica and NanoVibronix
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Biomerica and NanoVibronix is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Biomerica and NanoVibronix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NanoVibronix and Biomerica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomerica are associated (or correlated) with NanoVibronix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NanoVibronix has no effect on the direction of Biomerica i.e., Biomerica and NanoVibronix go up and down completely randomly.
Pair Corralation between Biomerica and NanoVibronix
Given the investment horizon of 90 days Biomerica is expected to generate 0.31 times more return on investment than NanoVibronix. However, Biomerica is 3.23 times less risky than NanoVibronix. It trades about -0.02 of its potential returns per unit of risk. NanoVibronix is currently generating about -0.11 per unit of risk. If you would invest 347.00 in Biomerica on May 7, 2025 and sell it today you would lose (32.00) from holding Biomerica or give up 9.22% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Biomerica vs. NanoVibronix
Performance |
Timeline |
Biomerica |
NanoVibronix |
Biomerica and NanoVibronix Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biomerica and NanoVibronix
The main advantage of trading using opposite Biomerica and NanoVibronix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomerica position performs unexpectedly, NanoVibronix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NanoVibronix will offset losses from the drop in NanoVibronix's long position.Biomerica vs. Applied DNA Sciences | Biomerica vs. Aytu BioScience | Biomerica vs. Bluejay Diagnostics | Biomerica vs. Movano Inc |
NanoVibronix vs. Heart Test Laboratories | NanoVibronix vs. ReShape Lifesciences | NanoVibronix vs. Inspira Technologies Oxy | NanoVibronix vs. Xenetic Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |